Beneficient 10-Q quarterly reports

Beneficient reports significant net losses, ongoing legal battles, and a former CEO's indictment for fraud, raising substantial doubt about its ability to continue as a going concern.

Beneficient reported a significant net loss for Q2 2025, raising substantial doubt about its ability to continue as a going concern, while facing multiple Nasdaq delisting threats and confirmed arbitration awards.

Beneficient's Q3 2025 report reveals a complex financial landscape marked by strategic shifts, legal proceedings, and efforts to maintain Nasdaq compliance.

Beneficient's Q2 2025 report reveals a complex financial picture, marked by a net income of $54.1 million, but also highlighting ongoing concerns about liquidity and substantial debt.

Beneficient reported a net income of $44.3 million for the quarter ended June 30, 2024, primarily driven by investment gains and a release of a loss contingency.

Beneficient's Q3 2024 report reveals a significant net loss, driven by a substantial goodwill impairment, and ongoing operational and financial challenges.